Industry

Report of our online technical stakeholder survey

Node image

 

The report of our online stakeholder survey is available here. Learn about benefits and barriers to QSARs use according to specialists, regulators and industry.

The results of this survey have been published in the open access literature as follow:

Mays C, Benfenati E and Pardoe S.
Use and perceived benefits and barriers of QSAR models for REACH: findings from a questionnaire to stakeholders
Chemistry Central Journal 2012, 6:159 doi:10.1186/1752-153X-6-159

http://journal.chemistrycentral.com/content/6/1/159

Summary Report by the Workshop: REACH and QSAR: What can we learn from case studies

Summary Report by the Workshop REACH&QSAR:What can we learn case studies - image
Document Subject: 

A summary report by the Workshop: REACH and QSAR: What can we learn from case studies? (Mario Negri Institute – Milano (Italy) April 6th 2011)

 

More information about the workshop and the outcomes here

VEGA

Vega logoUsing the VEGA platform, you can access a series of QSAR (quantitative structure-activity relationship) models for regulatory purposes, or develop your own model for research purposes.

The QSAR models available for regulatory purposes have been optimised in accordance with the REACH requirements.

Video Documentary: QSARs in REACH? - Uses, issues and priorities

The documentary 'QSARs in REACH?' is based on interviews with regulators, industry and QSAR developers, and addresses some of the key issues and priorities in the further use of QSARs within REACH. 

The documentary was first shown at the ORCHESTRA booth at the 2011 SETAC Europe conference in Milan.   Here it can be viewed online in 4 short separate sections.  The 20+ contributors are listed below and at the end of the final section, with our thanks to them.

 

COURSE ON IN-SILICO METHODS AND WORKSHOP ON REACH AND QSAR

Orchestra Banner for Workshop and Course
Date: 
Wed, 2011-04-06 00 - Thu, 2011-04-07 00

••• NEW: The workshop and course outcomes

Course on in-silico methods

Mario Negri Institute, Milan, Italy

7 April 2011

We have reached the limit of subscriptions to the course planned for April 5th. The course will be repeated on April 7th.

Usage of in-silico

7 reasons to use in-silico methods

1. Cost and feasibility

The REACH legislation requires industry to evaluate the toxicity not just of new chemicals, but also of the tens of thousands of existing chemical substances that are currently in use but have never been subject to regulatory testing.  Many argue that to achieve this by traditional in vivo testing would take decades, cost billions and consume many millions of vertebrates.  In addition to the time and costs for industry, there is a lack of laboratories in Europe capable of performing in vivo tests for such large numbers of substances.

Policy issues around computer-based methods as alternatives to animal testing

 

Questionnaire imageThe short questionnaire is our invitation to policy makers, industry managers, educators, political leaders, NGOs, investors, citizens and all others who are not specialists in toxicology to comment on some of the issues that are raised and/or addressed by computer-based (in silico) methods.

We really hope you can take a few minutes to complete it.  Please also email the link to others who may be interested.

 

 

Improving realistic use of in silico methods

Node image
Document Subject: 

The ORCHESTRA layman's report, entitled "Improving realistic use of in silico methods", gives an overview of the most significant resources developed by ORCHESTRA for people involved or interested in the use of in silico methods in REACH.

Each resource is briefly explained and the readers are provided with links or information about where they can download it or find more about it. This report has been developed with users’ needs in mind and together with the ORCHESTRA website, the introductive leaflet and the e-book is an important source of information.

Syndicate content
What's next